What's New

September 22, 2021

HNL Career Fair

Interested in a career at HNL Lab Medicine?

Join us at our next Career Fair, Wednesday, September 29, 2021 at 1 pm – 5:30 pm.

Located at 794 Roble Rd, Allentown, PA 18109-9110 (PARKING LOT)
On-the-spot interviews will be conducted

Read More
September 08, 2021

Martin K. Till, New President and CEO of HNL Lab Medicine, Starts with Strategic Plan to Accelerate Growth

Graphic-HNL-MartinTill-CEO-PR-sm.jpg

HNL Lab Medicine, a regional leader in high quality, innovative laboratory medicine services, announces the official start of Martin K. Till as president and CEO, transitioning from Matthew R. Sorrentino, Esq., who will retire Oct. 15 and continue in a consulting capacity for the next year.

Read More
July 16, 2021

HNL Lab Medicine Announces a New Patient Service Center in Hazleton, Pa.

HNL Lab Medicine, a regional leader in high quality, innovative laboratory medicine services, announces the opening of a patient center at 550 West Broad Street, Hazleton, Luzerne County. Patients can access this facility Monday to Friday from 7 a.m. to 5 p.m. and Saturdays 8 a.m. to noon. https://www.hnl.com/Hazleton 

Read More
July 07, 2021

HNL Lab Medicine Announces New Patient Service Center Location in Gateway Plaza, Chambersburg, Pa.

HNL Lab Medicine, a regional leader in high quality, innovative laboratory medicine services, is moving its Chambersburg patient center to the new Gateway Plaza, 497 Gateway Avenue. Patients can access this facility weekdays from 6 a.m. to 3:30 p.m. and Saturdays 7 a.m. to 11 a.m.
Read More
June 29, 2021

HNL Lab Medicine's Unseen Heroes

Presenting HNL Lab Medicine’s

Unseen Heroes Video — WATCH VIDEO

Read More

Rodney Wiltshire, PhD

Scientific Director, Cytogenetics
Rodney Wiltshire, Ph.D., is a graduate of the University of Michigan, where he received his doctor of philosophy degree in human genetics and completed a training fellowship at the National Human Genome Research Institute, National Institutes of Health. Dr. Wiltshire continued his research training as a post-doctoral fellow at Duke University Medical Center where he also completed the Clinical Cytogenetic Fellowship. He is board certified in Clinical Cytogenetics by the American Board of Medical Genetics and Genomics and is a Visiting Professor at the Universidad Nacional Pedro Ruiz Gallo in Lambayeque, Peru. His expertise and areas of interest include constitutional genetics, cancer genetics, and genomics, particularly utilizing cytogenetic and molecular genetic technologies like fluorescent in situ hybridization (FISH) and microarrays, to investigate inborn and neoplastic genetic abnormalities.